BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients-Reference-Cited by-同舟云学术

BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients

Published:2009 Issue:1 Volume:56 Page:89-97
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

ITO Yasuhiro¹,YOSHIDA Hiroshi¹,MARUO Rie²³,MORITA Shinji¹,TAKANO Toru²,HIROKAWA Mitsuyoshi¹,YABUTA Tomonori¹,FUKUSHIMA Mitsuhiro¹,INOUE Hiroyuki¹,TOMODA Chisato¹,KIHARA Minoru¹,URUNO Takashi¹,HIGASHIYAMA Takuya¹,TAKAMURA Yuuki¹,MIYA Akihiro¹,KOBAYASHI Kaoru¹,MATSUZUKA Fumio¹,MIYAUCHI Akira¹

Affiliation:

1. Kuma Hospital

2. Department of Laboratory Medicine, Osaka University Graduate School of Medicine

3. Division of Health Sciences, Osaka University Graduate School of Medicine

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/56/1/56_K08E-208/_pdf

Reference49 articles.

1. 1. Sobin LH and Wittekind CH eds (2002) UICC: TNM classification of malignant tumors, edn 6. New York, NY: Wiley-Liss

2. 2. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-fre survival. World J Surg 30: 780-786.

3. 3. Ito Y, Tomoda C, Uruno T, Takamura T, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29: 917-920.

4. Risk Factors Contributing to a Poor Prognosis of Papillary Thyroid Carcinoma: Validity of UICC/AJCC TNM Classification and Stage Grouping

5. 5. LiVolsi VA, Mazzaferri EL, Albores-Saavedra J (2004) Papillary carcinoma. In DeLeillis RA, Lloyd RV, Heitz PU et al. editors, Pathology and genetics of tumous of endocrine organs, Lyon, IARC Press, 2004; 57-66.

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors;Hormones;2024-09-03

2. Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma;Anticancer Research;2024-06-26

3. BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients;Oral Oncology;2024-05

4. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study;Clinical and Experimental Medicine;2024-04-12

5. TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-04-05